case_images: PMC10713788_01
case_images: (A) Pathology of the liver tissue: HE staining (X40). (B) Pathology of the liver tissue: HE staining (X100). (C) Pathology of the liver tissue: HE staining (X200). (D) Pathology of the liver tissue: MASSON staining (X200).
case_images: fmed-10-1285064-g0001.jpg
case_images: PMC10713788_01_fmed-10-1285064-g0001.jpg
case_images: F1
case_images: The biopsy also indicated partial hepatocyte atrophy and reduced portal veins in transitional regions, along with fibrous tissue hyperplasia (Figure 1).
case_images: (A) Spleen size was normal before surgery in 2018. (B) The spleen was significantly enlarged in 2022. (C) Liver size was normal before surgery in 2018. (D) The portal vein dilated significantly in 2022.
case_images: fmed-10-1285064-g0002.jpg
case_images: PMC10713788_01_fmed-10-1285064-g0002.jpg
case_images: F2
case_images: Examinations of the patient conducted over the past 5 years have revealed significant changes when compared to the full-abdomen routine scan performed before the surgery in 2018 and post-surgery in 2022 (Figure 2).
case_images: (A) Preoperative esophagogastroduodenoscopy showed no significant esophageal or gastric fundal varices. (B-F) Annual routine check-ups from 2019 to 2023 showed progressive aggravation of esophageal and gastric fundal varices.
case_images: fmed-10-1285064-g0003.jpg
case_images: PMC10713788_01_fmed-10-1285064-g0003.jpg
case_images: F3
case_images: However, subsequent annual routine examinations from 2019 to 2023 have shown a progressive worsening of esophageal and gastric varices (Figure 3).
case_images: Platelet counts started to decrease with the initiation of chemotherapy and have not recovered to date.
case_images: fmed-10-1285064-g0004.jpg
case_images: PMC10713788_01_fmed-10-1285064-g0004.jpg
case_images: F4
case_images: Platelet count, which began to decline after chemotherapy, has not yet returned to normal levels (Figure 4).